CRIP1 and leukemia: In this work, combined with ChIP-seq data, the CRIP1 expression was abnormally activated by the TNFα–NFκB signaling pathway, which promoted the proliferation of leukemia cells, thereby resulting in relapse and drug resistance of t (8;21) AML patients.